Literature DB >> 6943375

Biology of hepatocellular neoplasia in the mouse. I. Histogenesis of safrole-induced hepatocellular carcinoma.

M M Lipsky, D E Hinton, J E Klaunig, B F Trump.   

Abstract

A sequential, histologic analysis of the livers of male BALB/c mice chronically fed the hepatocarcinogen safrole (4,000 ppm) was performed at 2, 4, 8, 16, 24, 36, 52, and 75 weeks. The transplantability of selected lesions to syngeneic hosts was also assessed. Histopathologic liver alterations at 2, 4, 8, and 16 weeks induced hypertrophy of centrolobular hepatocytes, oval cell proliferation, fatty change in periportal hepatocytes, including basophilic, acidophilic, and clear cell, were noted. At 36 and 52 weeks, hepatocellular adenomas occurred in 4 of 10 and 7 of 10 mice, respectively. At 75 weeks they occurred in 5 of 5 mice. Adenomas were larger than a lobule in diameter compressed the adjacent parenchyma, and distorted the hepatic architecture. Individual adenomas were composed of a mixture of basophilic, acidophilic, clear, and lipid-laden cells, arranged in disorganized cords, one to three cells in thickness. None of the 10 adenomas tested grew upon subcutaneous transplantation into syngeneic hosts. Hepatocellular carcinomas (HPC) developed in 2 of 10 safrole-exposed mice at 52 weeks and 3 of 5 mice at 75 weeks. These lesions were large, multilobed and, unlike adenomas, seemed to invade adjacent parenchyma. The HPC were heterogeneous in cell composition. Their architecture was disorganized with trabeculae of 1-10 or more cells in thickness. No central veins or portal tracts were seen. All HPC proliferated when transplanted into syngeneic hosts. The results of this study demonstrated a sequential development of altered hepatocyte populations leading to HPC in safrole-treated mice. The transplantability of HPC indicated their malignant nature.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6943375

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

1.  Inhibitory effect of sialoadenectomy on hepatocellular tumourigenesis in male mice induced by 3'-methyl-4-dimethylaminoazobenzene.

Authors:  R Yamamoto; H Iishi; M Tatsuta; M Tsuji; N Terada
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  Oval cell proliferation in early stages of hepatocarcinogenesis in simian virus 40 large T transgenic mice.

Authors:  M Bennoun; M Rissel; N Engelhardt; A Guillouzo; P Briand; A Weber-Benarous
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

3.  Carcinogenicity of diethylnitrosamine in newborn, infant, and adult mice.

Authors:  S D Vesselinovitch; M Koka; N Mihailovich; K V Rao
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 4.  Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982.

Authors:  L S Gold; M de Veciana; G M Backman; R Magaw; P Lopipero; M Smith; M Blumenthal; R Levinson; L Bernstein; B N Ames
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

5.  Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene.

Authors:  R Yamamoto; M Tatsuta; N Terada
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

6.  Correlation between serum prolactin levels and hepatocellular tumorigenesis induced by 3'-methyl-4-dimethylaminoazobenzene in mice.

Authors:  R Yamamoto; H Iishi; M Tatsuta; T Yamamoto; K Koike; Y Kanda; A Miyake; M Tsuji; N Terada
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.